{
  "url": "https://openlegislation.uk/eu-directive-2020-1687/article-1",
  "json_url": "https://openlegislation.uk/eu-directive-2020-1687/article-1.json",
  "legislation": "eudr/2020/1687",
  "legislation_title": "Commission Delegated Directive (EU) 2020/1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of ‘drug’",
  "legislation_url": "https://openlegislation.uk/eu-directive-2020-1687",
  "path": "article/1",
  "kind": "article",
  "number": "1",
  "heading": "Amendment to Framework Decision 2004/757/JHA",
  "text": "In the Annex to Framework Decision 2004/757/JHA, the following point 17 is added:\n17.. ‘ N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene). ’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Commission Delegated Directive (EU) 2020/1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of ‘drug’, OJ L 379, 13.11.2020, p. 55.’"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2020/1687/article/1",
    "retrieved_at": "2026-11-01T15:21:23.177090+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}